Abstract
The contribution of polymorphisms in carcinogen metabolizing genes to overall cancer rates may vary widely between groups with differing allele frequencies and with varying levels of carcinogenic exposure. Their effects are modified by interactions with each other and with other genes, particularly those involved in DNA repair. Studies on the combined effects of particular polymorphisms on colorectal and other cancers, and also on intermediate markers such as DNA adduct formation, are discussed. Such susceptibility genes are of considerable scientific interest, but do not confer high enough risks to be clinically relevant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berwick M, Matullo G and Vineis P . (2002). Biomarkers of Environmentally Associated Disease SH Wilson, WA Suk, (eds). Lewis Publishers: Boca Raton.
Berwick M and Vineis P . (2000). J. Natl. Cancer Inst., 92, 874–897.
Burnet NG, Johansen J, Turesson I, Nyman J and Peacock JH . (1998). Int. J. Cancer, 79, 606–613.
Dybdahl M, Vogel, Frentz G, Wallin H and Nexo BA . (1999). Cancer Epidemiol. Biomark. Prev., 8, 77–81.
Eyfjord JE . (2000). Proceedings of the Workshop ‘Molecular Epidemiology: a new tool in cancer prevention’ F Perera, CC Harris, (eds). Keystone Symposia: Taos, February 10–15.
Garte S . (1998). Carcinogenesis, 19, 1329–1332.
Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell’Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC and Taioli E . (2001). Cancer Epidemiol. Biomark. Prev., 10, 1239–1248.
International Agency for Research on Cancer (1986). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, :Tobacco Smoking. IARC: Lyon.
Le Marchand L, Hankin JH, Pierce LM, Sinha R, Nerurkar PV, Franke AA, Wilkens LR, Kolonel LN, Donlon T, Seifried A, Custer LJ, Lum-Jones A and Chang W . (2002). Mutat Res., 506–507, 205–214.
Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, Masala G, Berrino F, Panico S, Tumino R, Vineis P and Palli D . (2003). Cancer Epidemiol. Biomark. Prev., 12, 674–677.
Nicas M and Lomax GP . (1999). J. Occup. Environ. Med., 41, 535–544.
Riboli E and Lambert L . (2002). IARC Science Publication No. 156. International Agency for Research on Cancer, Lyon.
Taioli E . (1999). Cancer Epidemiol. Biomark. Prev., 8, 727–728.
Vineis P, Alavanja M . and Garte S . (2004). Int J Cancer, 108, 2–7.
Vineis P, Malats N, Lang M, d’Errico A, Caporaso N, Cuzick J and Boffetta P . (1999). IARC Scientific Publication No. 148. International Agency for Research on Cancer, Lyon.
Vineis P and McMichael AJ. . (1996). Cancer Causes Control, 7, 479–486.
Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange RC, Stucker I, Sugimura H, Garte S, Gaspari L and Taioli E . (2003). Int. J. Cancer, 104, 650–657.
Vogelstein B and Kinzler KW . (1998). The Genetic Basis of Human Cancer. McGraw-Hill: New York.
Watson MA, Stewart RK, Smith GB, Massey TE and Bell DA . (1998). Carcinogenesis, 19, 275–280.
Weber WW . (1999). Mol. Diagn., 4, 299–307.
Ye Z and Parry JM . (2002). Med. Sci. Monit., 8, CR558–CR565.
Acknowledgements
This paper has been made possible by a grant of the European Union (QLK4-1999-00927) and a grant from the Compagnia di San Paolo (Torino) and from the Associazione Italiana Per La Ricerca Sul Cancro. I am grateful to Seymour Garte, Emanuela Taioli and Giuseppe Matullo for comments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vineis, P. Individual susceptibility to carcinogens. Oncogene 23, 6477–6483 (2004). https://doi.org/10.1038/sj.onc.1207897
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207897
Keywords
This article is cited by
-
Bedeutung des CYP1B1-Leu432Val-Polymorphismus nach PAK-Exposition
Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie (2015)
-
Evaluation of DNA damage in COPD patients and its correlation with polymorphisms in repair genes
BMC Medical Genetics (2013)
-
Cytochrome P450 1A1 Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls
Tumor Biology (2012)
-
STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement
European Journal of Epidemiology (2011)
-
The interval between cancer diagnosis among mothers and offspring in a population-based cohort
Familial Cancer (2007)